MINI FUTURE LONG - QUEST DIAGNOSTICS | Real-time Boerse Frankfurt Warrants 13:21:03 26/06/2024 BST | ||
| 2.09 EUR | -2.34% |
|
| Current month | -10.08% | ||
| 1 month | -12.65% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 26/06/24 | 2.09 | -2.34% |
| 25/06/24 | 2.14 | -6.55% |
| 24/06/24 | 2.29 | +4.57% |
| 21/06/24 | 2.19 | +4.29% |
| 20/06/24 | 2.1 | +5.00% |
Real-time Boerse Frankfurt Warrants
Last update June 26, 2024 at 01:21 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | 
BNP Paribas
|
| WKN | PZ0YY8 |
| ISIN | DE000PZ0YY85 |
| Date issued | 03/11/2023 |
| Strike | 115.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.17 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.85 € |
|---|---|
| Lowest since issue | 0.95 € |
| Spread | 0.05 € |
| Spread % | 2.33% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
138.3
USD
Average target price
147
USD
Spread / Average Target
+6.29%
- Stock Market
- Certificates
- Certificat
